Main > METABOLIC DISEASES > Metabolic Diseases. > HyperPhosphatemia > Treatment > Polymer > CrossLinked Poly(Styrene)

Product UK. B

PATENT ASSIGNEE'S COUNTRY UK
UPDATE 10.99
PATENT ASSIGNEE BTG International
PATENT CLAIMS Polystyrene polymer cross-linked by 1.5-8% with divinylbenzene & having a min. wt. av. MW 10,000 wherein 50-100% of aromatic groups are substituted with -NH-C(=NH)-NH2 in order to control phosphate uptake from diet &/or remove excess phosphate from blood
PATENT PHOTOCOPY Available on request

Want more information ?
Interested in the hidden information ?
Click here and do your request.


back